Neonatal pemphigus vulgaris

J Dermatol. 2008 Aug;35(8):529-35. doi: 10.1111/j.1346-8138.2008.00515.x.

Abstract

A male newborn with skin erosions was born to a 32-year-old woman who was under treatment for pemphigus vulgaris that had been diagnosed 16 months earlier. Antibodies to desmoglein (Dsg)1 and Dsg3 were analyzed by enzyme-linked immunosorbent assay. Index values of antibodies to Dsg1 and Dsg3 were 49 (normal index values, <14) and 121 (normal index values, <7), respectively. Those findings concluded a diagnosis of neonatal pemphigus vulgaris. No new vesicles or bullae appeared in the newborn after the birth. Non-corticosteroid ointments produced prompt epithelialization on the erosive lesions. All the eruptions disappeared in 3 weeks. The level of serum anti-Dsg3 autoantibodies when measured at the 76th day was negative (<5).

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Autoantibodies / blood
  • Biomarkers / blood
  • Desmoglein 1 / immunology
  • Desmoglein 3 / immunology
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Pemphigus / diagnosis*
  • Pemphigus / drug therapy
  • Pemphigus / pathology
  • Pregnancy
  • Pregnancy Complications
  • Skin / pathology
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Autoantibodies
  • Biomarkers
  • DSG1 protein, human
  • DSG3 protein, human
  • Desmoglein 1
  • Desmoglein 3